Share-based Payment Arrangements (Tables)

9 Months Ended

Sep. 24, 2022

Amounts Recognized in Financial Statements with Respect to Plans

Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):

	Thirty Nine Weeks Ended						Thirteen Weeks Ended
	September 24, 2022			September 25, 2021			September 24, 2022			September 25, 2021
Total cost of the Plans during the period	$	9,409		$	18,717		$	3,599		$	7,824
Amount of related income tax benefit recognized during the period		(5,219	)		(5,636	)		(949	)		(1,919	)
Net cost of the Plans during the period	$	4,190		$	13,081		$	2,650		$	5,905

Schedule of Information on Restricted Stock Units

The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:

	Number of RSUs			Weighted Average Grant Date Fair Value
Outstanding at December 25, 2021		209,399		$	102.90
Granted		49,825		$	139.54
Shares earned in excess of target (1)		91,497		$	92.58
Vested shares, including shares earned in excess of target		(177,146	)	$	95.48
Forfeited		(21,989	)	$	113.85
Outstanding at September 24, 2022		151,586		$	115.80

(1) Represents additional shares earned under each of the February 2, 2017, February 2, 2018 and February 1, 2019 RSU awards, as fiscal year 2021 financial results exceeded target performance level under each such award.

Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units

The following table summarizes information regarding the Company’s outstanding shares of non-vested restricted stock and Deferred Stock Units (defined below) under the Plans:

	Number of Shares and Deferred Stock Units			Weighted Average Grant Date Fair Value
Non-vested at December 25, 2021		56,436		$	125.16
Granted		25,354		$	152.54
Vested		(27,074	)	$	122.68
Forfeited		(6,921	)	$	144.45
Non-vested at September 24, 2022		47,795		$	138.30

Summary of Information Regarding Stock Options

The following table summarizes information regarding the Company’s outstanding stock options under the Plans:

	Number of Options			Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value (000s)
Options outstanding at December 25, 2021		8,570		$	55.42
Exercised		(4,100	)	$	54.36
Options outstanding at September 24, 2022		4,470		$	56.40		0.4	$	386
Options exercisable at September 24, 2022		4,470		$	56.40		0.4	$	386